Armour Pharmaceutical thyroid tablets
Check against the official notice below — it lists the full affected range.
Armour Pharmaceutical Company is replacing child-resistant safety caps on approximately 140,000 bottles of prescription thyroid tablets after Consumer Product Safety Commission testing found that some adults might be unable to properly reclose the caps during home use. The thyroid tablets themselves are safe and effective, and no recall of the product is being issued. Federal regulations require that at least 90% of adults tested be able to both open and properly close child-resistant packages to protect young children from accidental poisoning.
Armour voluntarily initiated this safety cap replacement program for packages in its warehouses and plans to continue its ongoing safety packaging efforts to maintain quality standards and comply with federal regulations. The company stopped distribution of the affected product upon receiving the test results and took immediate action to investigate and correct the problem. The source does not specify what consumers holding these bottles should do.
Written by software from the official notice below. Not reviewed by a lawyer.
Poisoning
December 12, 1978 Release # 78-104 Armour Replaces Safety Caps On Thyroid Tablets WASHINGTON, D.C. (Dec. 12) -- Armour Pharmaceutical Company and the U.S. Consumer Product Safety Commission (CPSC) today announced that Armour will replace the child-resistant caps on approximately 140,000 100-tablet bottles of prescription thyroid tablets. Efficacy and safety of the tablets themselves are not in question and no recall is involved. The firm voluntarily initiated the cap replacement program, which involves only those packages held in its warehouses, after Commission testing indicated that some adults might be unable to properly reclose the safety feature of the present package during use in the home. Regulations under the Poison Prevention Packaging Act currently require that at least 90% of those adults tested be able, not only to open the packages, but also to properly close them to protect young children from accidentally swallowing the contents. In addition to replacing caps on current inventory, Armour plans to continue its on-going safety packaging program to meet its own standards of quality and to assure compliance with CPSC regulations. In presenting this matter to the Commission, the staff acknowledged that upon receipt of the results of Commission testing, Armour promptly stopped distribution of the product in question and took immediate action to investigate and correct the problem
Official record: U.S. Consumer Product Safety Commission ↗
Republished from the official source above; details can change — the source record controls.